{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:40:42Z","timestamp":1780461642937,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T00:00:00Z","timestamp":1548460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13000-019-0784-6","type":"journal-article","created":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T12:02:37Z","timestamp":1548504157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Shuang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,26]]},"reference":[{"issue":"2","key":"784_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108. \n                    https:\/\/doi.org\/10.3322\/caac.21262\n                    \n                  .","journal-title":"CA Cancer J Clin"},{"key":"784_CR2","volume-title":"PDQ Cancer information summaries","author":"Screening PDQ, Prevention Editorial B","year":"2002","unstructured":"Screening PDQ, Prevention Editorial B. Endometrial Cancer Screening (PDQ(R)): health professional version. In:  PDQ Cancer information summaries. Bethesda (MD): National Cancer Institute (US); 2002."},{"issue":"12","key":"784_CR3","doi-asserted-by":"publisher","first-page":"e0189044","DOI":"10.1371\/journal.pone.0189044","volume":"12","author":"HI Kim","year":"2017","unstructured":"Kim HI, Schultz CR, Buras AL, Friedman E, Fedorko A, Seamon L, et al. Ornithine decarboxylase as a therapeutic target for endometrial cancer. PLoS One. 2017;12(12):e0189044. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0189044\n                    \n                  .","journal-title":"PLoS One"},{"issue":"11","key":"784_CR4","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1200\/jco.2004.07.184.","volume":"22","author":"GF Fleming","year":"2004","unstructured":"Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR, et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol. 2004;22(11):2159\u201366. \n                    https:\/\/doi.org\/10.1200\/jco.2004.07.184.","journal-title":"J Clin Oncol"},{"issue":"11 Suppl 2","key":"784_CR5","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1111\/IGC.0b013e3181f60af6","volume":"20","author":"CL Creutzberg","year":"2010","unstructured":"Creutzberg CL. Adjuvant chemotherapy for endometrial cancer: unproven. Int J Gynecol Cancer. 2010;20(11 Suppl 2):S60\u20133. \n                    https:\/\/doi.org\/10.1111\/IGC.0b013e3181f60af6\n                    \n                  .","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"784_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/GRF.0b013e318218c6d1","volume":"54","author":"MG Carmen Del","year":"2011","unstructured":"Del Carmen MG, Boruta DM 2nd, Schorge JO. Recurrent endometrial cancer. Clin Obstet Gynecol. 2011;54(2):266\u201377. \n                    https:\/\/doi.org\/10.1097\/GRF.0b013e318218c6d1\n                    \n                  .","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"784_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1083\/jcb.120.4.853","volume":"120","author":"AJ Savitz","year":"1993","unstructured":"Savitz AJ, Meyer DI. 180-kD ribosome receptor is essential for both ribosome binding and protein translocation. J Cell Biol. 1993;120(4):853\u201363.","journal-title":"J Cell Biol"},{"issue":"41","key":"784_CR8","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1038\/onc.2012.514","volume":"32","author":"HY Tsai","year":"2013","unstructured":"Tsai HY, Yang YF, Wu AT, Yang CJ, Liu YP, Jan YH, et al. Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78. Oncogene. 2013;32(41):4921\u201331. \n                    https:\/\/doi.org\/10.1038\/onc.2012.514\n                    \n                  .","journal-title":"Oncogene"},{"issue":"1","key":"784_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1559-0275-9-7","volume":"9","author":"D Telikicherla","year":"2012","unstructured":"Telikicherla D, Marimuthu A, Kashyap MK, Ramachandra YL, Mohan S, Roa JC, et al. Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer. Clin Proteomics. 2012;9(1):7. \n                    https:\/\/doi.org\/10.1186\/1559-0275-9-7\n                    \n                  .","journal-title":"Clin Proteomics"},{"issue":"5","key":"784_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/bjc.2015.260","volume":"113","author":"Y Pan","year":"2015","unstructured":"Pan Y, Cao F, Guo A, Chang W, Chen X, Ma W, et al. Endoplasmic reticulum ribosome-binding protein 1, RRBP1, promotes progression of colorectal cancer and predicts an unfavourable prognosis. Br J Cancer. 2015;113(5):763\u201372. \n                    https:\/\/doi.org\/10.1038\/bjc.2015.260\n                    \n                  .","journal-title":"Br J Cancer"},{"key":"784_CR11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2147\/cmar.s158013","volume":"10","author":"L Wang","year":"2018","unstructured":"Wang L, Wang M, Zhang M, Li X, Zhu Z, Wang H. Expression and significance of RRBP1 in esophageal carcinoma. Cancer Manag Res. 2018;10:1243\u20139. \n                    https:\/\/doi.org\/10.2147\/cmar.s158013\n                    \n                  .","journal-title":"Cancer Manag Res"},{"issue":"6","key":"784_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/cas.12666","volume":"106","author":"X Liang","year":"2015","unstructured":"Liang X, Sun S, Zhang X, Wu H, Tao W, Liu T, et al. Expression of ribosome-binding protein 1 correlates with shorter survival in Her-2 positive breast cancer. Cancer Sci. 2015;106(6):740\u20136. \n                    https:\/\/doi.org\/10.1111\/cas.12666\n                    \n                  .","journal-title":"Cancer Sci"},{"issue":"2","key":"784_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0020-7292(00)00300-3","volume":"70","author":"JL Benedet","year":"2000","unstructured":"Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. Int J Gynaecol Obstet. 2000;70(2):209\u201362.","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"784_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ijc.11101","volume":"105","author":"R Penzel","year":"2003","unstructured":"Penzel R, Hoegel J, Schmitz W, Blaeker H, Morresi-Hauf A, Aulmann S, et al. Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka. Int J Cancer. 2003;105(4):494\u20138. \n                    https:\/\/doi.org\/10.1002\/ijc.11101\n                    \n                  .","journal-title":"Int J Cancer"},{"issue":"3","key":"784_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/path.4836","volume":"241","author":"JC Lee","year":"2017","unstructured":"Lee JC, Li CF, Huang HY, Zhu MJ, Marino-Enriquez A, Lee CT, et al. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma. J Pathol. 2017;241(3):316\u201323. \n                    https:\/\/doi.org\/10.1002\/path.4836\n                    \n                  .","journal-title":"J Pathol"},{"key":"784_CR16","doi-asserted-by":"publisher","unstructured":"Gao W, Li Q, Zhu R, Jin J. La autoantigen induces ribosome binding protein 1 (RRBP1) expression through internal ribosome entry site (IRES)-mediated translation during cellular stress condition. Int J Mol Sci. 2016;17(7). \n                    https:\/\/doi.org\/10.3390\/ijms17071174\n                    \n                  .","DOI":"10.3390\/ijms17071174"},{"issue":"6","key":"784_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s12015-017-9762-0","volume":"13","author":"J Barrera-Ramirez","year":"2017","unstructured":"Barrera-Ramirez J, Lavoie JR, Maganti HB, Stanford WL, Ito C, Sabloff M, et al. Micro-RNA profiling of exosomes from marrow-derived mesenchymal stromal cells in patients with acute myeloid leukemia: implications in Leukemogenesis. Stem Cell Rev. 2017;13(6):817\u201325. \n                    https:\/\/doi.org\/10.1007\/s12015-017-9762-0\n                    \n                  .","journal-title":"Stem Cell Rev"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0784-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-019-0784-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0784-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,26]],"date-time":"2020-01-26T00:04:49Z","timestamp":1579997089000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-019-0784-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,26]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1186\/s13000-019-0784-6","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,26]]},"assertion":[{"value":"13 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Committee of the Harbin Medical University Cancer Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained the consent to publishing the paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"7"}}